Company intelligence / Profile preview

SonaCare Medical

Charlotte, North Carolina, United Statessonablate.com ↗

Ownership: Private
Development stage: Commercial

Overview

SonaCare Medical has commercialized the Sonablate system, the first FDA-approved focused ultrasound device for ablation of prostate tissue. The company also conducts clinical trials to evaluate safety and efficacy in minimally invasive prostate cancer treatment and other soft tissue disease applications using its HIFU technology. No detailed recent clinical results are publicly available.

Therapeutic areas: Oncology
Modalities: DeviceHigh Intensity Focused Ultrasound (HIFU)
Industry: Therapeutic Medical Devices

Partnerships

Catalyst Product Development Group Inc. – design/manufacturing partner for injection mold tooling and components of Sonablate device

Beyond the preview

Go deeper on SonaCare Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SonaCare Medical.

Explore the full profile